Skip to main content

Oxymatrine ameliorates myocardial injury by inhibiting oxidative stress and apoptosis via the Nrf2/HO-1 and JAK/STAT pathways in type 2 diabetic rats


The necessity of increasing the efficiency of organ preservation has encouraged researchers to explore the mechanisms underlying diabetes-related myocardial injuries. This study intended to evaluate the protective effects of oxymatrine (OMT) in myocardial injury caused by type 2 diabetes mellitus. A model of diabetic rats was established to simulate type 2 diabetes mellitus using an intraperitoneal injection of a single dose of 65 mg/kg streptozotocin with a high-fat and high-cholesterol diet, and diabetic rats were subsequently treated with OMT (60, 120 mg/kg) by gavage for 8 weeks. Thereafter, diabetic rats demonstrated notable decreases in left ventricular systolic pressure (LVSP), ±dp/dtmax, and in the activities of glutathione peroxidase, superoxide dismutase, and catalase. Moreover, we found notable increases in left ventricular end-diastolic pressure, fasting blood glucose, and malondialdehyde, as well as changes in cell apoptosis and decreased expression levels of Nrf2, HO-1, tyrosine protein kinase JAK (JAK), and signal transducer and transcription activator (STAT). Treatment with OMT alleviated all of the measured parameters. Collectively, these findings suggest that activation of the Nrf2/HO-1 and inhibition of the JAK/STAT signaling are involved in mediating the cardioprotective effects of OMT and also highlight the benefits of OMT in ameliorating myocardial injury in diabetic rats.

Peer Review reports


Diabetic cardiomyopathy is a unique myocardial disease in patients with diabetes and is characterized by persistent hyperglycemia and cardiac dysfunction [1, 2]. During continuous hyperglycemia, the excessive production or insufficient removal of mitochondrial reactive oxygen species (ROS) in the body leads to the occurrence of oxidative stress, which is a key influencing factor for diabetic microangiopathy, and is also a pivotal cause of diabetic cardiomyopathy [3, 4]. Oxidative stress under hyperglycemic conditions contributes to reduced antioxidant capacity and also accelerates myocardial injury and initiates mitochondrial oxidative damage in diabetes mellitus, which deteriorates cell apoptosis and necrosis [5, 6]. Nuclear factor erythroid 2-related factor 2 (Nrf2), an important activator of antioxidant responsive element (ARE), regulates downstream target genes such as HO-1 [7, 8]. Nrf2, a key activator of ARE, which activates Nrf2 to dissociate from Kelch-like ECH-related protein 1 and enter the nucleus, forms a heterodimer with the macrophage activator protein in the nucleus, binds to the ARE sequence, and is subsequently regulated by ARE, which is a specific DNA-promoter binding sequence and an external regulatory region for the expression of phase II detoxification enzymes and cytoprotective protein genes. Previous studies have verified that the Nrf2/HO-1 pathway plays an important role in oxidative stress, which is also involved in myocardial injury [9, 10].

The tyrosine protein kinase JAK (JAK)/signal transducer and transcription activator (STAT) signaling pathway is an intracellular signaling pathway involved in the modulation of stress-response gene expression, by mediating signals from the cell surface to the nucleus, which is regarded as a pivotal player in the response to multiple cardiac injuries such as myocardial ischemia/reperfusion (I/R) injury. Inhibition of JAK/STAT signaling decreases the synthesis of TGF-β 1, the release of inflammatory mediators, and autophagy. According to a previous study, oxymatrine (OMT) suppresses JAK/STAT inflammatory signaling in gastric cancer through inhibition of the interleukin (IL)-21R-mediated JAK2/STAT3 pathway [11]. Moreover, OMT inhibits tumor growth and deactivates STAT5 signaling in a xenograft model [12].

OMT, the main component of Sophora flavescens Aiton, possesses extensive pharmacological effects, including antioxidant [13], antifibrotic [14], and anti-inflammatory properties [15]. Moreover, it has been widely accepted as a traditional remedy in myocardial ischemic injury, as well as in renal, liver, intestinal, and brain I/R injury in animal models [16]. OMT also exerts a significant effect on aortic endothelial dysfunction via oxidative stress in diabetic rats [17]. However, OMT has not yet been reported to offer myocardial protection in diabetes-related myocardial injury in rats, which is associated with the Nrf2-mediated antioxidant response. Therefore, using a model of myocardial injury in type 2 diabetic mellitus (T2DM) rats, the aim of this study was to investigate the potential effect of OMT on myocardial injury and elucidate the role of the Nrf2/HO-1 and JAK2/STAT3 signaling pathways in diabetic rats.

Materials and methods


Male SD rats weighing 160–200 g were purchased by the Experimental Animal Center of Changsha Social Work College. The rats were given free access to food and water. All experiments were carried out in accordance with the guidelines for the Care and Use of Laboratory Animals (NIH Publication No. 85–23, revised 1996 and Ethics Committees in Science: European Perspectives) and were approved by Changsha Social Work College Medicine Animal Care and Use Committee (XIANG 202109). All possible efforts were made to alleviate animal suffering.

Reagents and antibodies

Oxymatrine (purity > 98%) was purchased from Shanghai Aladdin Biochemical Technology Co., Ltd. Malondialdehyde (MDA) ( S0131M), glutathione peroxidase (GSH-Px)( S0059S), superoxide dismutase (SOD)( S0087), and catalase (CAT)( S0082) were purchased from Beyotime (Shanghai, China). IL-6 and NF-κB (p65) were obtained from ELISA kits (R&D Systems Inc., Minneapolis, MN, USA; and MyBioSource, Southern California, San Diego, USA). Secondary antibodies, such as Alexa Fluor®488 labeled and Alexa Fluor®594 labeled goat anti-rabbit IgG (H + L), primary antibodies pSTAT3 (ab76315) were obtained from Abcam (Cambridge, UK). The primary antibodies STAT3 (bs-1658R and bsm-52235R) was purchased from Bioss. anti-Janus kinase 2(JAK2) ( 3230) and pJAK2 ( 3771) were obtained from Cell Signaling Technology. TUNEL staining kit was obtained from Sigma-Aldrich Co., Ltd.

Diabetic rat model development

After 1 week of adaptive feeding, the animals were randomly assigned to one of the following groups: the control group (n = 10), T2DM group (n = 10), OMT (60 mg/kg) group (n = 10), or OMT (120 mg/kg) group (n = 10) [17]. The control rats were fed a regular diet, while the experimental group rats were fed a high-fat diet (consisting of 70% standard laboratory chow, 15% carbohydrate, 10% lard, and 5% yolk powder) as previously described [18, 19]. After 4 weeks of high-fat diet, the rats in the experimental group were injected with streptozotocin (STZ; 65 mg/kg, dissolved in 0.1 mol/L sodium citrate buffer; pH 4.4) intraperitoneally. The control group was intraperitoneally injected with a corresponding volume of citrate buffer (0.1 mol/L). Fasting blood glucose (FBG), oral glucose tolerance test (OGTT), and intraperitoneal glucose tolerance test (IPGTT) were conducted using venous blood samples to verify the establishment of a T2DM model. Rats in the T2DM groups were further randomly assigned into the OMT group (60 mg/kg) and the OMT group (120 mg/kg) (dissolved in saline) combined with a high-fat diet. Rats in the control and T2DM groups intragastrically received the same volume of saline once a day for 8 weeks.

Measurement of left ventricular function index

The rats were anesthetized with an intraperitoneal injection of sodium pentobarbital (concentration, 3%; 60 mg/kg) [13, 20], and fixed on the operating table in the supine position, with an incision in the middle of the neck and endotracheal intubation. The right common carotid artery of the rat was separated and inserted into the left ventricle. The arterial cannula was connected to the pressure transducer, and also connected to the BL-420 N biological signal acquisition and analysis system (Chengdu Techman Instrument) in order to record the LVSP, the left ventricle, the ±dp/dtmax and LVEDP as previously described [21, 22]. Subsequently, venous blood was collected for biochemical analysis. All the rats were sacrificed by exsanguination following anesthesia, the tissues were collected for the following experiments.

Histological examination

The hearts were collected and embedded in paraffin. The heart was sliced into 5-μm thick section, stained with HE and observed under a light microscope (Olympus Corporation). Histological examination was carried out in a blinded trial by an experienced pathologist. The scoring standard was recorded as follows: 0 indicated no damage, 1 indicated less than 25% damage, 2 indicated 25–50% damage, 3 indicated 50–75% damage, and 4 indicated more than 75% damage [18, 23].

Evaluation of FBG, OGTT, and IPGTT

The FBG, OGTT, and IPGTT plasma concentrations were determined spectrophotometrically using a SpectraMax M5 instrument (Molecular Devices, LLC) and commercially available kits, following the manufacturer’s instructions.

Determination of the levels of MDA, GSH-Px, SOD, and CAT

The supernatant from tissues was collected, and the activities of SOD, GSH-Px, MDA, and CAT were determined using the colorimetric kits [24].

Measurement of reactive oxygen species

The procedures of ROS measurement were according to manufacturer’s instructions. The tissue slices were incubated with DCFH-DA (cat# S0033, Beyotime, China) for 10 min at 37 °C. Following three washes with phosphate buffer solution for 1 min, the tissue slices were immediately photographed under an inverted fluorescence microscope. The mean fluorescence intensity was analyzed using the ImageJ software.

Myocardial ultrastructural observation

Ultrastructural examination was performed as previously described [11]. Fresh rat myocardium was obtained and cut into 1-mm3 pieces, immersed in 2.5% glutaraldehyde at 4 °C and subsequently fixed. Sections were stained using uranyl acetate and lead bismuth citrate, and sections were detected using a transmission electron microscopy (Carl Zeiss AG).

TUNEL staining

The levels of apoptosis were assessed using a commercial kit (cat. S7110, Sigma Aldrich). Briefly, tissues were excised and fixed in 4% paraformaldehyde in PBS at room temperature for 24 h. The fixed tissues were embedded in paraffin and stained. The numbers of apoptotic cells and total myocardial cells were counted in three randomly selected fields (magnification, × 200) under an immunofluorescence microscope. The apoptosis rate was defined as the mean percentage of apoptotic cells.

Determination of IL-6 and NF-κB (p65)

Cardiac levels of IL-6 (cat: SRP4145, Sigma Aldrich) and NF-κB (p65) (cat:kt30141, Wuhan Merck Biotechnology Co., Ltd) were detected using ELISA kits in accordance with the respective manufacturers’ instructions.

Reverse transcription-quantitative (RT-q)PCR

Total RNA was extracted using a RNeasy Mini kit and purified using 75% ethanol. The purified total RNA (200 ng/sample) was reverse transcribed into cDNA using a transcription kit. qPCR reactions were performed in triplicate using a SYBR® Green Master Mix and run on a LightCycler 480 system. The following thermocycling conditions were used: Pre-denaturation at 95 °C for 5 min; followed by 30 cycles of denaturation at 95 °C for 50 sec, annealing at 56.1 °C (Nrf2 and HO-1) and 59.4 °C (β-actin) for 50 sec, and extension at 72 °C for 50 sec; and a final total extension at 72 °C for 10 min. The following primers were used: Nrf2 forward, 5′-TTC CTC TGC TGC CAT TAG TCA GTC-3′ and reverse, 5′-GCT CTT CCA TTT CCG AGT CAC TG-3′, the length of the amplified product is 441 bp; HO-1 forward, 5′-ATC GTG CTC GCA TGA ACA CT-3′.

and reverse, 5′-CCA ACA CTG CAT TTA CAT GGC-3′, the length of the amplified product is 441 bp; and GADPH forward, 5′-TCC CAT CAC CAT CTT CCA-3′ and reverse, 5′-CAT CAC GCC ACA GTT TCC-3′, the length of the amplified product is 632 bp. The primers were synthesized by Guangzhou RiboBio. The relative gene expression was quantified using the 2-∆∆Cq method [25].

Western blot

Protein was extracted from the myocardial tissue in RIPA buffer together with phosphatase and protease inhibitors (PMSF). The protein concentration was evaluated by BCA method. Tissue lysates were added with 4x Laemmlisample buffer, boiled and separated by SDS-PAGE. Proteins were transferred to a PVDF membrane (Bio-Rad, Hercules, CA). After nonspecific blocking with skim milk or BSA for 1 h, the membranes were probed with primary antibodies, including pSTAT3 (Abcam, 1:5000), STAT3 (Bioss, 1:1000), JAK2 (Cell Signaling Technology, 1:1000) and pJAK2 (Cell Signaling Technology, 1:1000) in 5 ml blocking buffer overnight at 4 °C. Next, the membranes were washed 4 times with Tris-buffered saline supplemented with 0.1% Tween 20 (TBST) and incubated with an appropriate HRP-conjugated secondary antibody. Membranes were washed 4 times with TBST, incubated with an ECL solution (Millipore) and d imaging was conducted using an BioRad imaging system.

Statistical analysis

Statistical analysis was performed using GraphPad Prism 6.0 (GraphPad Software, Inc.), and data were expressed as the mean ± standard deviation. Statistical differences were assessed using Student’s t test between two groups, or using one-way ANOVA between more than two groups, followed by Tukey’s post-hoc tests. The level of statistically significant difference was set at P < 0.05.


Diabetic rats exhibit exacerbated dysglycemia and cardiac dysfunction

Compared with the control group, diabetic rats showed significantly increased levels of non-fasting and fasting serum glucagon, accompanied by markedly impaired non-fasting PG, fasting PG, IPGTT, and OGTT, indicating that the diabetic rat model was constructed successfully (Fig. 1A, P < 0.01). Compared with the control group, cardiac functions were markedly deteriorated, as confirmed by the decreases in LVSP (Fig. 1B, P < 0.05 or P < 0.01), + dp/dtmax (Fig. 1D, P < 0.05 or P < 0.01), and -dp/dtmax (Fig. 1E, P < 0.05 or P < 0.01), and the increases in LVEDP (Fig. 1C) and FBG (Fig. 1F, P < 0.05 or P < 0.01). These findings indicated marked increase in blood glucose and cardiac dysfunction in diabetic rats, suggesting that diabetes exacerbated myocardial injury, which was attenuated following OMT treatment.

Fig. 1
figure 1

Confirmation of a diabetic rat model establishment. OMT attenuates ventricular hemodynamic parameters and FBG level in diabetic rats. A Non-fasting plasma glucose, fasting plasma glucose, IPGTT, and OGTT following 7 days of streptozotocin injection. B LVSP; C LVEDP; D + dp/dtmax; E -dp/dtmax; F FBG; Data are expressed as the mean ± standard deviation (n = 8). *P < 0.05 compared with the control group. #P < 0.05 compared with the diabetic group

Effects of OMT on histopathology in myocardial tissues

Ultrastructure of myocardial tissues was assessed by electron microscopy. As demonstrated in Fig. 2A, myocardial musculature was arranged regularly and neatly, the Z-line was clear, and abundant mitochondria were observed in the cytoplasm. In the diabetic rats, ultrastructural changes demonstrated notable heterogeneous subcellular and extracellular space abnormalities in the myocardial tissues, which were attenuated by OMT.

Fig. 2
figure 2

Effects of OMT on the histopathological changes and apoptosis in myocardial tissues in diabetic rats. A Ultrastructural changes determined using transmission electron microscopy; representative micrographs are magnified at 5000×; B Histopathological changes in myocardial tissues using H&E staining; representative micrographs are magnified at 200×; C Myocardial injury score was quantified. *P < 0.05 compared with the control group. #P < 0.05 compared with the diabetic group

As demonstrated in Fig. 2B, compared with the control group, diabetes caused focal confluent necrosis of the muscle fibers, with inflammatory cell infiltration, edema, and myophagocytosis, along with extravasation of red blood cells. OMT treatment significantly attenuated the aforementioned effects in myocardial tissues (Fig. 2C,, P < 0.05 or P < 0.01 or P < 0.001). Moreover, mild edema with a significant reduction in myocardial necrosis was observed.

Effects of OMT on lipid peroxidation and inflammation in diabetic rats

Colorimetric kits were used to detect the expression of inflammatory cytokines IL-6 and NF-κB in myocardial tissue. The results showed that the expression levels of IL-6 and NF-κB in diabetic rats were obviously increased compared with those in the control group (Fig. 3A and B, P < 0.01). Compared with diabetic rats, the expression levels of IL-6 and NF-κB in the OMT (60 mg/kg) (P < 0.05) and OMT (120 mg/kg) (P < 0.01) groups decreased in a dose-dependent manner.

Fig. 3
figure 3

Effects of OMT on lipid peroxidation and inflammatory mediators in diabetic rats. A IL-6; B NF-κB; C MDA; D SOD, E GSH-Px, and (F) CAT. Data are expressed as the mean ± standard deviation (n = 6). *P < 0.05 compared with the control group. #P < 0.05 compared with the diabetic group

Next, the expression of oxidative stress–related indicators MDA, ROS, GSH, and SOD was detected by the corresponding kits. We found that the level of MDA in the myocardium of the diabetic rats was significantly increased, while the activity levels of GSH-Px, SOD, and CAT were significantly decreased (Fig. 3C-F, P < 0.05 or P < 0.01). Compared with the diabetic rats, OMT treatment significantly reduced the levels of MDA in the myocardium and significantly increased the activity levels of GSH-Px, SOD, and CAT. These experimental results suggest that OMT reduces inflammation and lipid peroxidation.

Effects of OMT on oxidative stress in myocardial tissues

Oxidative stress is one of the critical causes of myocardial injury in diabetes [26]. Increased ROS and oxidative stress have been regarded as one of the important mechanisms contributing to diabetic cardiomyopathy. As shown in Fig. 4A and B, we found markedly increased ROS production in diabetic rats, suggesting that diabetes exacerbated myocardial oxidative stress, which was attenuated following OMT treatment (P < 0.05 or P < 0.01).

Fig. 4
figure 4

Effects of OMT on the levels of oxidative stress in the myocardial tissues of diabetic rats. A relative fluorescence intensity of DCFH-DA; and (B) the myocardial tissue slides stained using DCFH-DA. Data are expressed as the mean ± standard deviation (n = 8). *P < 0.05 compared with the control group. #P < 0.05 compared with the diabetic group

Effects of OMT on apoptosis in myocardial tissues

To investigate the effects of OMT on the levels of apoptosis in myocardial tissues, TUNEL assay was performed. As demonstrated in Fig. 5A and B, compared with the control group, a significant increase in the number of apoptotic cells was observed in diabetic rats (P < 0.05 or P < 0.01). However, OMT treatment significantly reduced the number of apoptotic cells in myocardial tissues. These results indicate that OMT may ameliorate myocardial injury partly through the inhibition of apoptosis.

Fig. 5
figure 5

Effects of OMT on apoptosis in myocardial tissues of diabetic rats. A Apoptosis was detected by TUNEL staining. B The statistical analysis of the apoptosis percentage. *P < 0.05 compared with the control group. #P < 0.05 compared with the diabetic group

Effects of OMT on the expression levels of Nrf2 and HO-1 in myocardial tissues

To determine whether OMT mediates the protection against oxidative stress, which is associated with the Nrf2/HO-1 signaling pathway, the levels of Nrf2 and HO-1 were determined by RT-PCR and western blot. As demonstrated in Fig. 6, the Nrf2 and HO-1 mRNA levels in the diabetic rats were significantly downregulated (P < 0.05). OMT treatment significantly increased the mRNA expression of Nrf2 and HO-1. Moreover, western blot analysis demonstrated that Nrf2 and HO-1 protein levels were notably upregulated, and OMT treatment decreased the levels of these oxidant-related proteins. Additionally, OMT promoted Nrf2 translocating from cytoplasm to nuclei, indicating Nrf2 functions as a major regulator in oxidative stress (Supplementary Figure, P < 0.05). These results demonstrate that OMT ameliorates diabetes by exerting antioxidant effects.

Fig. 6
figure 6

Effects of OMT on the mRNA and protein expression levels of Nrf2 and HO-1 in the myocardial tissues of diabetic rats (n = 3). A and B Representative images and quantitative analysis of western blotting. C and D mRNA expression levels of Nrf2 and HO-1 quantified using reverse transcription–quantitative PCR. **P < 0.01 compared with the control group; #P < 0.05 and ##P < 0.01 compared with the diabetic group

Effects of OMT on the phosphorylation of JAK2 and STAT3

The JAK–STATs signaling pathway has been shown to play a role in a variety of biological processes, including cell activation, proliferation, differentiation, autophagy, and apoptosis [27], and the activation of JAK2–STAT3 is involved in the protection of myocardial tissue [28]. However, whether the protective effect of JAK2–STAT3 is associated with amelioration of oxidative stress and the relationship of OMT with JAK2–STAT3 signaling are unclear. It has previously been reported that STAT3 is a critical downstream element of JAK2 [29]. Therefore, the effect of OMT on the JAK2/STAT3 signaling pathway was assessed. As shown in Fig. 7, there was a significant increase in the levels of phosphorylated JAK2 and STAT3 in diabetic rats (P < 0.05 or P < 0.01). However, OMT treatment significantly downregulated the levels of JAK2 and STAT3 phosphorylation. These results suggest that OMT exerts ameliorative effects on cardiac injury via suppressing JAK2 and STAT3 phosphorylation.

Fig. 7
figure 7

Effects of OMT on JAK2 and STAT3 protein levels in the hearts of diabetic rats. A and B Representative images of western blotting. The blots were cut prior to hybridisation with antibodies during blotting. Data are expressed as mean ± SD (n = 3). *P < 0.05 compared with the control group; #P < 0.05 and ##P < 0.01 compared with the diabetic group


Diabetic cardiomyopathy is characterized by persistent hyperglycemia that is caused by myocardial metabolism disorders and microvascular diseases, and it ultimately leads to myocardial structural damage and cardiac dysfunction [29]. The present study demonstrated that the heart function of diabetic rats was significantly decreased and the myocardial ultrastructural damage was significantly aggravated, which further confirmed that the myocardial injury of the diabetic rat model was successfully established.

OMT is a main active gradient extracted from Sophora flavescens Ait. A number of studies have demonstrated that OMT exerts numerous pharmacological effects, including anti-viral, anti-inflammatory, antioxidant, antifibrotic [13,14,15,16,17], and antiapoptotic properties [5, 13], which has attracted a high level of attention from investigators [6, 13,14,15,16]. In the present study, diabetic rats with myocardial injury were received OMT intragastrically for 8 weeks. The results demonstrated that OMT treatment significantly decreased FBG and improved the indicators of heart function and myocardial ultrastructure. In addition, OMT treatment decreased the level of blood glucose. These results suggest that OMT exhibits protective effects on cardiac function and ultrastructural damage in a dose-dependent manner in diabetic rats.

Previous studies have demonstrated that oxidative stress and changes in the antioxidant defense systems deteriorate myocardial tissues in diabetic rats [26, 30]. Further studies have also shown that a decreased antioxidant status is an important contributor to myocardial impairment in diabetic rats [31]. Therefore, deterioration of antioxidant systems may be an important mechanism underlying increased oxidative stress in diabetes. Moreover, the content of MDA and the activities of GSH-Px, SOD, and CAT, important antioxidant enzymes in the body, reflected the degree of oxidative injury. The results of the present study demonstrated that hyperglycemia notably increased the level of MDA in myocardial tissue and markedly decreased the activities of GSH-Px, SOD, and CAT, suggesting that hyperglycemia may cause severe oxidative stress injury in diabetic rats. OMT intervention reversed the aforementioned dysfunctions, suggesting that OMT may increase the activity of antioxidant enzymes, decrease the production of lipid peroxides, and reduce oxidative stress injury in diabetic rats.

HO-1, the downstream target gene of Nrf2, is an important antioxidant protein [32]. HO-1, also known as heat shock protein 32, is a stress protein induced by multiple factors. In the presence of oxygen and NADPH, HO-1 degrades heme to produce biliverdin, free iron, and CO. Bilirubin, a derivative of biliverdin in the body, is a strong endogenous antioxidant that inhibits lipid peroxidation [33]. Therefore, HO-1 and its products exert antioxidant actions in diabetic dysfunctions [34]. Results of previous studies have confirmed that downregulation of the Nrf2/HO-1 antioxidant signaling pathway deteriorated oxidative damage in cerebral ischemia. Moreover, a previous study revealed that OMT activated the Nrf2/HO-1 pathway and attenuated the oxidative stress injury caused by renal I/R [24]. These studies highlighted the involvement of the Nrf2/HO-1 pathway in diabetes-associated myocardial disturbances. The present study further demonstrated that oxidative stress accelerated the pathogenesis of myocardial dysfunction in diabetes. The expression levels of Nrf2 and HO-1 in the myocardial tissue were notably increased, and these expression levels decreased following treatment with OMT in a dose-dependent manner. This finding suggests that OMT may enhance the antioxidant capacities via upregulation of the Nrf2/HO-1 signaling pathway in diabetic rats.

Inflammation has been reported as one of the early events that accelerates the progression of diabetic myocardial injury. Our findings showed that OMT significantly lowered proinflammatory cytokines, showing significant anti-inflammatory activity. This result is consistent with the pronounced antioxidant effect of OMT, since oxidative stress is the main trigger for the release of proinflammatory cytokines [35, 36]. In fact, oxidative stress and inflammation are inextricably linked, generating and amplifying each other [35]. Numerous studies have demonstrated that Nrf2 downregulates NF-κB, a transcription factor that affects multiple cytokines, including IL-6 [37]. Therefore, the decreased IL-6 level in the OMT-treated group may be related to the enhanced expression of Nrf2 protein and the subsequent decrease of NF-κB level.

Increasing amount of evidence indicate that multiples of mechanisms involved in cell apoptosis in myocardial injury, including activation of SIRT1-Nrf2 [38], LKB-1/AMPK/Akt pathway and suppression of GSK-3β and p38α/MAPK pathway [39] and so on. And our understanding of diabetes-associated myocardial injury events at apoptosis has advanced substantially. The JAK/STAT pathway is involved in many important biological processes such as cell proliferation, differentiation, apoptosis and immune regulation [40] and several reports have proposed that JAK/STAT signalling is associated with cardiac dysfunction in diabetes [41, 42]. In diabetes, IL-6 inhibits the viability and apoptosis of pancreatic beta-cells via modulation of microRNA-22 in the JAK/STAT signaling pathway [43]. Previous studies have demonstrated that high glucose induces the activity of the JAK/STAT signaling pathway, leading to TGF-β1 activation and the subsequent increase in cardiac fibroblasts [44]. Our results suggest that diabetes caused notable increases in the phosphorylation of JAK2 and STAT3 and the levels of TGF-β1. Previous studies have demonstrated that IL-6 activates the JAK/STAT signaling pathway; thus, the pronounced increases in p-JAK2 and p-STAT3 may be attributed to the elevated level of proinflammatory cytokines in diabetic rats [45]. Conversely, the overt anti-inflammatory activity of OMT revealed an inhibitory effect on p-JAK2, p-STAT3, and TGF-β1 [46]. OMT was found to downregulate JAK2 and STAT3 phosphorylation in multiple pathophysiological states [47, 48]. Thus, the JAK2/STAT3 pathway may be considered to be of vital importance in ameliorating the effects of OMT against diabetic cardiomyopathy.

However, there were some limitations regarding the application of OMT for myocardial injury in diabetic rats. For example, in vitro investigations into the effects of OMT are required. In addition, to determine whether the JAK2/STAT3 pathway mediates the cardioprotective activity of OMT, the use of an inhibitor or short hairpin RNA is required, and further studies must be carried out.

Collectively, this study provides evidence that the cardioprotective effects of OMT may be associated with the inhibition of the Nrf2/HO-1 and JAK/STAT pathways and an increase in the activity of antioxidant enzymes in diabetic rats.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.


  1. Dillmann WH. Diabetic cardiomyopathy. Circ Res. 2019;124(8):1160–2.

    Article  CAS  Google Scholar 

  2. Jia G, Whaley-Connell A, Sowers JR. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease. Diabetologia. 2018;61(1):21–8.

    Article  CAS  Google Scholar 

  3. Luc K, Schramm-Luc A, Guzik TJ, Mikolajczyk TP. Oxidative stress and inflammatory markers in prediabetes and diabetes. J Physiol Pharmacol. 2019;70(6):809–24.

  4. Lu S, Liao Z, Lu X, Katschinski DM, Mercola M, Chen J, et al. Hyperglycemia acutely increases cytosolic reactive oxygen species via O-linked GlcNAcylation and CaMKII activation in mouse ventricular myocytes. Circ Res. 2020;126(10):e80–96.

    Article  CAS  Google Scholar 

  5. Sun HJ, Xiong SP, Wu ZY, Cao L, Zhu MY, Moore PK, et al. Induction of caveolin-3/eNOS complex by nitroxyl (HNO) ameliorates diabetic cardiomyopathy. Redox Biol. 2020;32:101493.

    Article  CAS  Google Scholar 

  6. Sangweni NF, Mosa RA, Dludla PV, Kappo AP, Opoku AR, Muller CJF, et al. The triterpene, methyl-3beta-hydroxylanosta-9,24-dien-21-oate (RA3), attenuates high glucose-induced oxidative damage and apoptosis by improving energy metabolism. Phytomedicine. 2021;85:153546.

    Article  CAS  Google Scholar 

  7. Luo J, Yan D, Li S, Liu S, Zeng F, Cheung CW, et al. Allopurinol reduces oxidative stress and activates Nrf2/p62 to attenuate diabetic cardiomyopathy in rats. J Cell Mol Med. 2020;24(2):1760–73.

    Article  CAS  Google Scholar 

  8. Włodarski A, Strycharz J, Wróblewski A, Kasznicki J, Drzewoski J, Śliwińska A. The role of microRNAs in metabolic syndrome-related oxidative stress. Int J Mol Sci. 2020;21(18):6902.

    Article  Google Scholar 

  9. Shen Z-Y, Sun Q, Xia Z-Y, Meng Q-T, Lei S-Q, Zhao B, et al. Overexpression of DJ-1 reduces oxidative stress and attenuates hypoxia/reoxygenation injury in NRK-52E cells exposed to high glucose. Int J Mol Med. 2016;38(3):729–36.

    Article  CAS  Google Scholar 

  10. Ma W, Guo W, Shang F, Li Y, Li W, Liu J, et al. Bakuchiol alleviates hyperglycemia-induced diabetic cardiomyopathy by reducing myocardial oxidative stress via activating the SIRT1/Nrf2 signaling pathway. Oxidative Med Cell Longev. 2020;2020:3732718.

    Article  Google Scholar 

  11. Huang Y, Zhang J, Wang G, Chen X, Zhang R, Liu H, et al. Oxymatrine exhibits anti-tumor activity in gastric cancer through inhibition of IL-21R-mediated JAK2/STAT3 pathway. Int J Immunopathol Pharmacol. 2018;32:2058738418781634.

    Article  Google Scholar 

  12. Young Yun Jung, Muthu K. Shanmugam, Acharan S. Narula, Chulwon Kim, Jong Hyun Lee, Ojas A. Namjoshi, Bruce E. Blough,Gautam Sethi,Kwang Seok Ahn. Oxymatrine attenuates tumor growth and deactivates STAT5 signaling in a lung Cancer xenograft model. Cancers (Basel) 2019; 11(1): 49.

    Article  CAS  Google Scholar 

  13. Huang Y, Li X, Zhang X, Tang J. Oxymatrine ameliorates memory impairment in diabetic rats by regulating oxidative stress and apoptosis: involvement of NOX2/NOX4. Oxidative Med Cell Longev. 2020;2020:3912173.

    Article  Google Scholar 

  14. Lan X, Zhao J, Zhang Y, Chen Y, Liu Y, Xu F. Oxymatrine exerts organ- and tissue-protective effects by regulating inflammation, oxidative stress, apoptosis, and fibrosis: from bench to bedside. Pharmacol Res. 2020;151:104541.

    Article  CAS  Google Scholar 

  15. Xiang X, Tu C, Li Q, Wang W, Huang X, Zhao Z, et al. Oxymatrine ameliorates imiquimod-induced psoriasis pruritus and inflammation through inhibiting heat shock protein 90 and heat shock protein 60 expression in keratinocytes. Toxicol Appl Pharmacol. 2020;405:115209.

    Article  CAS  Google Scholar 

  16. Avila-Carrasco L, Majano P, Sánchez-Toméro JA, Selgas R, López-Cabrera M, Aguilera A, et al. Natural plants compounds as modulators of epithelial-to-mesenchymal transition. Front Pharmacol. 2019;10:715.

    Article  CAS  Google Scholar 

  17. Wang L, Li X, Zhang Y, Huang Y, Zhang Y, Ma Q. Oxymatrine ameliorates diabetes-induced aortic endothelial dysfunction via the regulation of eNOS and NOX4. J Cell Biochem. 2019;120(5):7323–32.

    Article  CAS  Google Scholar 

  18. Santilli F, Lapenna D, La Barba S, Davì G. Oxidative stress- related mechanisms affecting response to aspirin in diabetes mellitus. Free Radic Biol Med. 2015;80:101–10.

    Article  CAS  Google Scholar 

  19. King AJF. The use of animal models in diabetes research. Br J Pharmacol. 2012;166(3):877–94.

    Article  CAS  Google Scholar 

  20. Zhan L, Zhang Y, Wating S, Zhang Q, Chen R, Zhao B, et al. The roles of autophagy in acute lung injury induced by myocardial ischemia reperfusion in diabetic rats. J Diabetes Res. 2018;2018:5047526.

    Article  Google Scholar 

  21. Lei Q, Yi T, Chen C. NF-κB-Gasdermin D (GSDMD) Axis couples oxidative stress and NACHT, LRR and PYD domains-containing protein 3 (NLRP3) Inflammasome-mediated cardiomyocyte Pyroptosis following myocardial infarction. Med Sci Monit. 2018;24:6044–52.

    Article  CAS  Google Scholar 

  22. Khdhiri E, Mnafgui K, Ncir M, Feriani A, Ghazouani L, Hajji R, et al. Cardiopreventive capacity of a novel (E)-N'-(1-(7-methoxy-2-oxo-2H-chromen-3-yl) ethylidene)-4-methylbenzenesulfonohydrazide against isoproterenol-induced myocardial infarction by moderating biochemical, oxidative stress, and histological parameters. J Biochem Mol Toxicol. 2021;35(6):e22747.

    Article  CAS  Google Scholar 

  23. Shujun X, Bingxin W, Zhong B, Lin L, Ding Y, Jin X, et al. Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2) /system xc−/ glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis. Bioengineered. 2021;12(2):10924–34.

    Article  Google Scholar 

  24. Jiang G, Liu X, Wang M, Chen H, Chen Z, Qiu T. Oxymatrine ameliorates renal ischemia-reperfusion injury from oxidative stress through Nrf2/HO-1 pathway. Acta Cir Bras. 2015;30(6):422–9.

    Article  CAS  Google Scholar 

  25. Livak and Schmittgen. Analysis of relative gene expression data using real-time quantitative PCR and the 2-DDct method. Methods. 2001;25:402–8.

    Article  Google Scholar 

  26. Zhao D, Yang J, Yang L. Insights for oxidative stress and mTOR signaling in myocardial ischemia/reperfusion injury under diabetes. Oxidative Med Cell Longev. 2017;2017:6437467.

    Article  Google Scholar 

  27. Yu S, Guo H, Luo Y, Chen H. Ozone protects cardiomyocytes against ischemia/reperfusion injury: regulating the heat shock protein 70 (HPS70) expression through activating the JAK2/STAT3 pathway. Bioengineered. 2021;12(1):6606–16.

    Article  CAS  Google Scholar 

  28. Boengler K, Hilfifiker-Kleiner D, Drexler H, Heusch G, Schulz R. The myocardial JAK/STAT pathway: from protection to failure. Pharmacol Ther. 2008;120:172–85.

    Article  CAS  Google Scholar 

  29. Costantino S, Paneni F, Mitchell K, Mohammed SA, Hussain S, Gkolfos C, et al. Hyperglycaemia-induced epigenetic changes drive persistent cardiac dysfunction via the adaptor p66(Shc). Int J Cardiol. 2018;268:179–86.

    Article  Google Scholar 

  30. Lejay A, Fang F, John R, Van JA, Barr M, Thaveau F, et al. Ischemia reperfusion injury, ischemic conditioning and diabetes mellitus. J Mol Cell Cardiol. 2016;91:11–22.

    Article  CAS  Google Scholar 

  31. Chien CY, Wen TJ, Cheng YH, Tsai YT, Chiang CY, Chien CT. Diabetes upregulates oxidative stress and downregulates cardiac protection to exacerbate myocardial ischemia/reperfusion injury in rats. Antioxidants (Basel). 2020;9(8):679.

    Article  CAS  Google Scholar 

  32. Barakat BM, Ahmed HI, Bahr HI, Elbahaie AM. Protective effect of Boswellic acids against doxorubicin-induced hepatotoxicity: impact on Nrf2/HO-1 defense pathway. Oxidative Med Cell Longev. 2018;2018:8296451.

    Article  Google Scholar 

  33. Ayer A, Zarjou A, Agarwal A, Stocker R. Heme Oxygenases in cardiovascular health and disease. Physiol Rev. 2016;96(4):1449–508.

    Article  CAS  Google Scholar 

  34. Negi G, Nakkina V, Kamble P, Sharma SS. Heme oxygenase-1, a novel target for the treatment of diabetic complications: focus on diabetic peripheral neuropathy. Pharmacol Res. 2015;102:158–67.

    Article  CAS  Google Scholar 

  35. Sharma A, Tate M, Mathew G, Vince JE, Ritchie RH, de Haan JB. Oxidative stress and NLRP3-Inflammasome activity as significant drivers of diabetic cardiovascular complications: therapeutic implications. Front Physiol. 2018;9:114.

    Article  Google Scholar 

  36. Abdelsamia EM, Khaleel SA, Balah A, Abdel Baky NA. Curcumin augments the cardioprotective effect of metformin in an experimental model of type I diabetes mellitus; impact of Nrf2/HO-1 and JAK/STAT pathways. Biomed Pharmacother. 2019;109:2136–44.

    Article  CAS  Google Scholar 

  37. Feng Y, Cui R, Li Z, Zhang X, Jia Y, Zhang X, et al. Methane alleviates acetaminophen-induced liver injury by inhibiting inflammation, oxidative stress, endoplasmic reticulum stress, and apoptosis through the Nrf2/HO-1/NQO1 signaling pathway. Oxidative Med Cell Longev. 2019;2019:7067619.

    Article  Google Scholar 

  38. Zhang B, Zhai M, Li B, Liu Z, Li K, Jiang L, et al. Honokiol ameliorates myocardial ischemia/reperfusion injury in type 1 diabetic rats by reducing oxidative stress and apoptosis through Activating the SIRT1-Nrf2 signaling pathway. Oxid Med Cell Longev. 2018;2018:3159801.

    Google Scholar 

  39. Al-Damry NT, Attia HA, Al-Rasheed NM, Al-Rasheed NM, Mohamad RA, Al-Amin MA, et al. Sitagliptin attenuates myocardial apoptosis via activating LKB-1/AMPK/Akt pathway and suppressing the activity of GSK-3β and p38α/MAPK in a rat model of diabetic cardiomyopathy. Biomed Pharmacother. 2018;107:347–58.

    Article  CAS  Google Scholar 

  40. Ming X, Li XY, Song L. Baicalin regulates macrophages polarization and alleviates myocardial ischaemia/reperfusion injury via inhibiting JAK/STAT pathway. Pharm Biol. 2020;58(1):655–63.

    Article  Google Scholar 

  41. Tang G, Li S, Zhang C, Chen H, Wang N, Feng Y. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management. Acta Pharm Sin B. 2021;11(9):2749–67.

    Article  CAS  Google Scholar 

  42. Zhang Y, Jin D, Kang X, Zhou R, Sun Y, Lian F, et al. Signaling pathways involved in diabetic renal fibrosis. Front Cell Dev Biol. 2021;9:696542.

    Article  Google Scholar 

  43. Xinhua W, Tao Y, Ji N, Huang Y, Gao L, Shi W, et al. IL6R inhibits viability and apoptosis of pancreatic beta-cells in type 2 diabetes mellitus via regulation by miR-22 of the JAK/STAT signaling pathway. Diabetes Metab Syndr Obes. 2019;12:1645–57.

    Article  Google Scholar 

  44. Zhang Y, Jin D, Kang X, Zhou R, Sun Y, Lian F, et al. Signaling pathways involved in diabetic renal fibrosis. Front Cell Dev Biol. 2021;9:696542.

    Article  Google Scholar 

  45. Junren C, Xiaofang X, Huiqiong Z, Gangmin L, Yanpeng Y, Xiaoyu C, et al. Pharmacological activities and mechanisms of Hirudin and its derivatives - a review. Front Pharmacol. 2021;12:660757.

    Article  Google Scholar 

  46. Jiang Y, Sang W, Wang C, Haiming L, Zhang T, Zhuoying Wang Y, et al. Oxymatrine exerts protective effects on osteoarthritis via modulating chondrocyte homoeostasis and suppressing osteoclastogenesis. J Cell Mol Med. 2018;22(8):3941–54.

    Article  CAS  Google Scholar 

  47. 2019 CIS Annual Meeting. Immune Deficiency & Dysregulation North American Conference. J Clin Immunol. 2019;39(Suppl 1):1–151.

    Google Scholar 

  48. Luo Y, Yin S, Jia L, Zhou S, Shao Y, Bao X, et al. Tumor microenvironment: a prospective target of natural alkaloids for cancer treatment. Cancer Cell Int. 2021;21:386.

    Article  Google Scholar 

Download references


Not applicable.


This work was funded by Hunan Province Natural Science Foundation (grant no. 2020JJ7090) and school-level cultivation projects for Changsha Social Work College (22mypy112).

Author information

Authors and Affiliations



YH and BH designed and undertook experiments, and analyzed, interpreted and presented results for group discussions. YH, BH, XL and CS performed some of the experiments and confirm the authenticity of all the raw data. XL, LL and JH provided methods, and was involved in the interpretation of results for the manuscript. XL, LL, CS and JH made substantial contributions to the conception and design of the study. YH, BH, XL, LL and JH have read and approved the final manuscript. The author(s) read and approved the final manuscript.

Corresponding authors

Correspondence to Jianbin He or Lijing Liu.

Ethics declarations

Ethics approval and consent to participate

All experiments were approved by Changsha Social Work College Medicine Animal Care and Use Committee (XIANG 202109) and authorized by the Ethics Committee of Changsha Social Work College, all experiments were performed in accordance with relevant guidelines and regulations. All methods are reported in accordance with ARRIVE guidelines for the reporting of animal experiments.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Huang, Y., He, B., Song, C. et al. Oxymatrine ameliorates myocardial injury by inhibiting oxidative stress and apoptosis via the Nrf2/HO-1 and JAK/STAT pathways in type 2 diabetic rats. BMC Complement Med Ther 23, 2 (2023).

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI:


  • Oxymatrine
  • Diabetes
  • Oxidative stress
  • Apoptosis
  • Myocardial injury
  • Inflammation